Last updated: 2026-09-16 11:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Daxor Corporation (DXR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $11.55, with a market capitalisation of $65.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.56 to $14.76. This page covers its latest market performance, valuation, price trends and company information.
$65.78M | |
$11.18 | |
$24.60 | |
$3.40 | |
$11.27 | |
15.33K | |
10.61K | |
-- | |
$14.76 | |
$8.56 | |
-- | |
-- |
Daxor Corporation (DXR) is trading at $11.09 in pre-market trading as of 2026-09-15 23:31:00, down 1.57% ($0.18) from the previous close of $11.27
Pre-market trading shows how investors are pricing DXR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Daxor Corporation (DXR) moved from $10.27 to $11.55, representing a gain of 12.46% ($1.28).
The stock traded between $9.90 and $12.07 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 61.01 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 48.2%
DXR is currently trading at $11.55, placing it 48.2% of the way from its 52-week low of $8.56 to its 52-week high of $14.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 750 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Daxor Corporation (DXR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.